2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2024-03-30
±³À°ÀÏÀÚ : 2024-03-30
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦
±³À°ÁÖÁ¦ : 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå»öÀü¿¬±¸È¸
´ã´çÀÚ : ±èÈñ¿µ
¿¬¶ôó : 0502-277-1919
À̸ÞÀÏ : stroke@stroke.or.kr
±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:00~09:20 Interpretation of long-term monitoring in ESUS patients Á¤¿äÇÑ(¿¬¼¼ÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:20~09:50 ESUS Case series - cardiologist view Â÷¸íÁø(¿ï»êÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:50~10:05 ESUS Case series - neurologist view °¹Î°æ(ÀÌÈÀÇ´ë½Å°æ°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:05~10:20 Clinical Implications of Atrial Fibrillation Detection Using Wearable Devices in Patients With Cryptogenic Stroke (CANDLE-AF) Trial results of inter-rim analysis ¼ÛÅÂÁø(ÀÌÈÀÇ´ë ½Å°æ°ú)
Åä·Ð 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:20~10:30 Discussion ( )
ÈÞ½Ä 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:30~10:50 Coffee Break ( )
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:50~11:10 Transthoracic echocardiography for stroke patients ¹ÚÀçÇü(Ãæ³²ÀÇ´ë ¼øȯ±â³»°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:10~11:30 Transesophageal Echocardiography for stroke patients ¹è´ëȯ(ÃæºÏÀÇ´ë ¼øȯ±â³»°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:30~11:50 Cardiac MRI ÀüÀºÁÖ(¼¿ïÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:50~12:10 Cardiac CT Ȳ¼ºÈ£(°í·ÁÀÇ´ë ¿µ»óÀÇÇаú)
Åä·Ð 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:10~12:30 Discussion ( )
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:30~13:30 CHAT GPT in research ¹ÚÇüÁØ(¿ï»êÀÇ´ë Á¤º¸ÀÇÇаú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:30~13:50 Stroke-heart syndrome: Underlying mechanism and clinical manifestation Á¤Áø¸¸(°í·ÁÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:50~14:20 Stroke-heart syndrome: Recent advance and current challenges ¾È¼ºÈ£(ºÎ»êÀÇ´ë ½Å°æ°ú)
Åä·Ð 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:20~14:30 Discussion ( )
ÈÞ½Ä 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:30~14:50 Coffee Break ( )
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:50~15:10 Work up of ESUS considering lesion pattern ±è¹üÁØ(¼¿ïÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:10~15:30 ESUS patient results with ROS-ESUS data ¼¿ì±Ù(¼º±Õ°üÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:30~15:50 ILR vs 7day-monitoring ±è¹üÁØ(¿ï»êÀÇ´ë ½Å°æ°ú)
Åä·Ð 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:50~16:20 Discussion ( )